Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)

Go back to Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

March 4, 2025 7:30 AM EST

WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for... More